• Corporate VC of Eisai, a leading pharma that develops drugs for Alzheimer's disease & cancer• Investing with a strategic focus on aging-related diseases: neurodegeneration, cancer and others

• Investing in breakthrough science, platforms and proven teams to address unmet medical needs• Enabling win-win partnerships among portfolio companies, Eisai and collaborating pharma/VC firms

ProTgen aims to make thymus great again to prevent/treat cancer and neurodegenerative diseases.

eGenesis is revolutionizing human organ xenotransplantation by providing CRISPR-edited, humanized pig organs.

Iambic Therapeutics is pioneering the invention of physics-informed generative AI tools, aimed at drastically accelerating small molecule drug discovery.

Hyku Biosciences is pioneering the next generation of high precision covalent medicine by focusing non-cysteine amino acids (H,Y,K...) of "undruggable" targets.

Tune Therapeutics is a global leader in developing CRISPR-based epigenome editing therapeutics for common diseases.https://www.genengnews.com/news/epigenetic-editing-in-non-human-primates-presented-by-tune-at-asgct/

RiboX Therapeutics is the first clinical-stage circular RNA (circRNA) company, founded on the pioneering work of its scientific founder, Ling-Ling Chen, in the biogenesis and functions of circRNA. With its unique protein-coding and non-coding capabilities, circRNA has the potential to overcome the current limitations of mRNA therapeutics.https://scholar.google.com/citations?user=0UNkhq4AAAAJ

Casma Therapeutics is advancing the next generation bio-degradation innovation based on autophagy.

Delivering RNA and protein drugs across the blood-brain barrier (BBB) to treat neurodegenerative diseases. https://ophidion.com/

Pyrotech is founded on Shao Feng's seminal work, which illuminated the mechanism of 'Pyroptosis'. This novel form of cell death controls infection by activating strong immune responses.https://scholar.google.com/citations?user=wLg0PUQAAAAJ

Founded by proven entrepreneurs, Travera is using a breakthrough innovation from MIT to measure individual cancer cells’ weight and responses in order to match patients with drugs quickly in real clinics.

Kernal Biologics is building the next generation mRNA therapeutic platform with greater cell-specific targeting and expression.

Orange Health is India's fastest diagnostic lab- Get tested at home in 60 minutes.

Vitable Health provides affordable, delightful primary & urgent care health plans for hourly workers with experienced nurses on the frontline.

-Conducted deep scientific & market research of various fields in healthcare and wrote case studies of public healthcare companies to identify unmet needs and/or emerging trends in healthcare-Built a science-first data-driven healthcare team and iterated the protocol of deal sourcing, scientific due diligence, management interviews and investment memo drafting-Focused on investing in disruptive technology platforms, emerging therapeutic modalities and the intersection of AI and healthcare-Led investments in 20+ companies globally, such as ClouDr. (HKG:09955), Pyrotech Therapeutics, Singleron Bio, Menlo Bio, Silexon, Vitable Health, Dynasty Gene, Travera, Kernal Biologics, etc...

-Performed deal sourcing of early-stage startups, and conducted scientific and commercial due diligence for healthcare companies-Established and maintained a network of entrepreneurs, venture capitalists and key opinion leaders from academia and the industry

-Conducted the science and technology due diligence of healthcare companies, and drafted investment reports leading to direct investments in two US-based healthcare companies-Led the scientific due diligence on investment of Rani Therapeutics (NASDAQ: RANI), a robotic pill company

-Integrated skin genetic data, survey data and facial imaging AI to improve skin disease diagnosis accuracy and personalize treatment-Won Y Combinator (YC) Fellowship F3 2016 (admission rate: 1.8%) and was couched by 2 YC partners

- Built the genetic content database and set up the genetic curation Standard Operating Procedure (SOP)- Led the Whole Genome Sequencing (WGS) interpretation team and supported the genetic report pipeline

Bioinformatics, Biostatistics

• Rheumatoid arthritis big data discovery research with Electronic Medical Records (EMR) under Prof. Tianxi Cai• Combined PheWAS and GWAS data to model rheumatoid arthritis and treatment outcomes.

• Analyzed the coverage of AmpliSeq Whole Exome Panel using various statistical and bioinformatic tools• President of Bay Area Intern Association

Cancer Genomics

Study cancer biology and genomics

• Led two projects in monitoring and modeling the protein-protein interaction between novel pharmaceutical targets (G-protein coupled receptors) and G proteins. • Participated in a project of constructing microRNA library for Type 1 Diabetes genetic research.• Published first-authored papers on high-impact journals such as Nature Chem. Biol.

• Participated in a national project of studying H5N1 avian influenza virus spreading in southern China

• Used molecular optical imaging to monitor the activity of β-secretase and study the pathogenesis of Alzheimer’s disease.• Won the Excellence in Undergraduate Thesis Award

• Reported scientific breakthroughs, educational reform and health news on campus.• Published reports, including SARS epidemic-related news, on city and provincial newspapers